The risk or severity of adverse effects can be increased when promazine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with tiapride.


The risk or severity of adverse effects can be increased when thiopental is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with doxazosin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 4-Methoxyphenol.


The risk or severity of adverse effects can be increased when Pregabalin is combined with nefazodone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with labetalol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when trazodone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when amcinonide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when lorazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when clonidine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when bumetanide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with mefloquine.


The risk or severity of adverse effects can be increased when Melatonin is combined with butalbital.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when enflurane is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when diflunisal is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Torasemide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when cerulenin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Propiverine.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with citalopram.


The risk or severity of adverse effects can be increased when bumetanide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when alprazolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when diazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when tacrolimus is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when HEROIN is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when nabumetone is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when apomorphine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amphotericin b is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with glutethimide.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with oxycodone.


The risk or severity of adverse effects can be increased when suprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when losartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with gabapentin.


The risk or severity of adverse effects can be increased when clonidine is combined with felbamate.


The risk or severity of adverse effects can be increased when lorazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when flurazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when sulindac is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when clenbuterol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when haloperidol is combined with zopiclone.


The risk or severity of adverse effects can be increased when losartan is combined with captopril.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when lithium ion is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when losartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when enflurane is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with desipramine.


The risk or severity of adverse effects can be increased when indomethacin is combined with diflorasone.


The risk or severity of adverse effects can be increased when amcinonide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methadone is combined with Perospirone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Mometasone.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with trandolapril.


The risk or severity of adverse effects can be increased when lorazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when bromazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Articaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Articaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with triamterene.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when nabumetone is combined with desoximetasone.


The risk or severity of adverse effects can be increased when nicardipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with methazolamide.


The risk or severity of adverse effects can be increased when buspirone is combined with procaine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when loxapine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when retinol is combined with Bexarotene.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when cetirizine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Olopatadine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when rasagiline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with zonisamide.


The risk or severity of adverse effects can be increased when ethotoin is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when rasagiline is combined with sulpiride.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with flunisolide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with acemetacin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with felodipine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when amifostine is combined with amphotericin b.


The risk or severity of adverse effects can be increased when oxaprozin is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ondansetron is combined with butamben.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when paroxetine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when loxapine is combined with butorphanol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with tetracaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when methysergide is combined with doxorubicin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with glutethimide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with apraclonidine.


The risk or severity of adverse effects can be increased when quazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with prazepam.


The risk or severity of adverse effects can be increased when HEROIN is combined with bumetanide.


The risk or severity of adverse effects can be increased when HEROIN is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when isoxsuprine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when loxapine is combined with risperidone.


The risk or severity of adverse effects can be increased when barnidipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when lorazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with nimesulide.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with meperidine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with histamine.


The risk or severity of adverse effects can be increased when THYMOL is combined with Pinaverium.


The risk or severity of adverse effects can be increased when irbesartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when codeine is combined with propofol.


The risk or severity of adverse effects can be increased when codeine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when lorazepam is combined with zaleplon.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with butamben.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with mefloquine.


The risk or severity of adverse effects can be increased when hexetidine is combined with bepridil.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when methysergide is combined with cocaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when metolazone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when tioconazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when oxymorphone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with cetirizine.


The risk or severity of adverse effects can be increased when metolazone is combined with bumetanide.


The risk or severity of adverse effects can be increased when trazodone is combined with topiramate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with phenobarbital.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with citalopram.


The risk or severity of adverse effects can be increased when flurazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when phenytoin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when bromazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when morniflumate is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when acemetacin is combined with difluprednate.


The risk or severity of adverse effects can be increased when acemetacin is combined with halcinonide.


The risk or severity of adverse effects can be increased when morniflumate is combined with fenbufen.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Toloxatone.


The risk or severity of adverse effects can be increased when proparacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when proparacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when proparacaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with tizanidine.


The risk or severity of adverse effects can be increased when lorazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when fexofenadine is combined with desipramine.


The risk or severity of adverse effects can be increased when loratadine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when mesalamine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when leflunomide is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when lidocaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when propofol is combined with butalbital.


The risk or severity of adverse effects can be increased when LISURIDE is combined with roxithromycin.


The risk or severity of adverse effects can be increased when thioridazine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ondansetron is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with etoposide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when propofol is combined with nifedipine.


The risk or severity of adverse effects can be increased when propofol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when zotepine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when diazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with clonidine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with maprotiline.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with acebutolol.


The risk or severity of adverse effects can be increased when Cladribine is combined with leflunomide.


The risk or severity of adverse effects can be increased when pancuronium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with galanthamine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when benazepril is combined with propranolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Mometasone is combined with malathion.


The risk or severity of adverse effects can be increased when lidocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with antipyrine.


The risk or severity of adverse effects can be increased when Normethadone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with promethazine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with clonazepam.


The risk or severity of adverse effects can be increased when clopidogrel is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when flurazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when flurazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when benazepril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Nabilone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when nelfinavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when amoxapine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Efonidipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when mecamylamine is combined with irbesartan.


The risk or severity of adverse effects can be increased when bupivacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Tramadol is combined with perphenazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with bifonazole.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when promethazine is combined with desipramine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when fenbufen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when risperidone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with zonisamide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Metixene.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Butethal is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ipratropium is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with celecoxib.


The risk or severity of adverse effects can be increased when Caspofungin is combined with gabapentin.


The risk or severity of adverse effects can be increased when azelastine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when timolol is combined with fosinopril.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with penbutolol.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with quinapril.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when amoxapine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when lidocaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with bumetanide.


The risk or severity of adverse effects can be increased when alclofenac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Milnacipran is combined with haloperidol.


The risk or severity of adverse effects can be increased when ramipril is combined with suprofen.


The risk or severity of adverse effects can be increased when clonidine is combined with clidinium.


The risk or severity of adverse effects can be increased when isoflurane is combined with nisoldipine.


The risk or severity of adverse effects can be increased when losartan is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when isoflurane is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when prilocaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with mepivacaine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when prilocaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with triprolidine.


The risk or severity of adverse effects can be increased when terbinafine is combined with barnidipine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when brotizolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when clopidogrel is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with mefloquine.


The risk or severity of adverse effects can be increased when thioridazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when naratriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trimipramine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with brotizolam.


The risk or severity of adverse effects can be increased when Droxicam is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when buspirone is combined with tetracaine.


The risk or severity of adverse effects can be increased when chloroquine is combined with flunisolide.


The risk or severity of adverse effects can be increased when Droxicam is combined with amcinonide.


The risk or severity of adverse effects can be increased when bromazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when nicergoline is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when meperidine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when zotepine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with paramethasone.


The risk or severity of adverse effects can be increased when etodolac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Metixene is combined with Tramadol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Articaine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when meperidine is combined with bromazepam.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nimodipine.


The risk or severity of adverse effects can be increased when baclofen is combined with clomipramine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Asenapine.


The risk or severity of adverse effects can be increased when scopolamine is combined with propantheline.


The risk or severity of adverse effects can be increased when methocarbamol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when apomorphine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with spironolactone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with triprolidine.


The risk or severity of adverse effects can be increased when amisulpride is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when procyclidine is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when valsartan is combined with metoprolol.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when secobarbital is combined with nalbuphine.


The risk or severity of adverse effects can be increased when quinapril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when enflurane is combined with Halazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with proparacaine.


The risk or severity of adverse effects can be increased when leflunomide is combined with alclometasone.


The risk or severity of adverse effects can be increased when secobarbital is combined with oxazepam.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with etizolam.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ipratropium is combined with Desloratadine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when docetaxel is combined with Valrubicin.


The risk or severity of adverse effects can be increased when propofol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when tolterodine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with desipramine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with fenbufen.


The risk or severity of adverse effects can be increased when spironolactone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when risperidone is combined with lidocaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with lidocaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with amsacrine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Fospropofol.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nisoldipine.


The risk or severity of adverse effects can be increased when pergolide is combined with topotecan.


The risk or severity of adverse effects can be increased when sertraline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Etomidate.


The risk or severity of adverse effects can be increased when chloroquine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with bupivacaine.


The risk or severity of adverse effects can be increased when estazolam is combined with baclofen.


The risk or severity of adverse effects can be increased when fosinopril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when butabarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when butabarbital is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when morniflumate is combined with ibuprofen.


The risk or severity of adverse effects can be increased when thiamylal is combined with HEROIN.


The risk or severity of adverse effects can be increased when dyclonine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when dyclonine is combined with amoxapine.


The risk or severity of adverse effects can be increased when trandolapril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when bromazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with desipramine.


The risk or severity of adverse effects can be increased when temazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when chloroxine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when midazolam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when temazepam is combined with haloperidol.


The risk or severity of adverse effects can be increased when floctafenine is combined with epirizole.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with nitrazepam.


The risk or severity of adverse effects can be increased when trimipramine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Micafungin is combined with nimesulide.


The risk or severity of adverse effects can be increased when clozapine is combined with triamterene.


The risk or severity of adverse effects can be increased when meprobamate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with formestane.


The risk or severity of adverse effects can be increased when lidocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when sotalol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when tolmetin is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with clonidine.


The risk or severity of adverse effects can be increased when diazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when Halazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with propranolol.


The risk or severity of adverse effects can be increased when levorphanol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when felbamate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when alprazolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Telmisartan.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Desloratadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with apraclonidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with mepivacaine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with methyldopa.


The risk or severity of adverse effects can be increased when vinblastine is combined with clozapine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Benidipine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when hexetidine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when hexetidine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when fosinopril is combined with tolmetin.


The risk or severity of adverse effects can be increased when Talniflumate is combined with nimesulide.


The risk or severity of adverse effects can be increased when amoxapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Vecuronium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with diflunisal.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with cinoxacin.


The risk or severity of adverse effects can be increased when practolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when trimipramine is combined with tiagabine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ethotoin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with prilocaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with antipyrine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Icatibant.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when lithium ion is combined with butamben.


The risk or severity of adverse effects can be increased when procaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Articaine.


The risk or severity of adverse effects can be increased when selegiline is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with resveratrol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with glutethimide.


The risk or severity of adverse effects can be increased when selegiline is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Salsalate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with promazine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with spironolactone.


The risk or severity of adverse effects can be increased when midazolam is combined with olanzapine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with physostigmine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with diazepam.


The risk or severity of adverse effects can be increased when flunisolide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when thiopental is combined with Fospropofol.


The risk or severity of adverse effects can be increased when felbamate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with clonazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when cerulenin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when amiodarone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when betamethasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when triazolam is combined with dibucaine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nifedipine.


The risk or severity of adverse effects can be increased when prazosin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when timolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Aliskiren.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when propofol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ramipril is combined with nisoldipine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with alclometasone.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with epirizole.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with meclizine.


The risk or severity of adverse effects can be increased when buspirone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with cetirizine.


The risk or severity of adverse effects can be increased when donepezil is combined with nicotine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with protriptyline.


The risk or severity of adverse effects can be increased when enflurane is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when thioridazine is combined with diazepam.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Apremilast is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when butamben is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when progesterone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when butamben is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fenbufen is combined with betamethasone.


The risk or severity of adverse effects can be increased when tioconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when memantine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when buspirone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with thiopental.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with quazepam.


The risk or severity of adverse effects can be increased when clomipramine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when buspirone is combined with triazolam.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with oxprenolol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when temazepam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Trospium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with gabapentin.


The risk or severity of adverse effects can be increased when nicergoline is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when quinapril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with halothane.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with doxazosin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with edrophonium.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with maprotiline.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with desipramine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when timolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when propofol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when quetiapine is combined with enflurane.


The risk or severity of adverse effects can be increased when nabumetone is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when diazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when midazolam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when midazolam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with flumethasone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Desloratadine.


The risk or severity of adverse effects can be increased when zopiclone is combined with quetiapine.


The risk or severity of adverse effects can be increased when furazolidone is combined with dipivefrin.


The risk or severity of adverse effects can be increased when prazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with epoprostenol.


The risk or severity of adverse effects can be increased when Carbetocin is combined with clomipramine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with bupivacaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when amobarbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Pregabalin is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Etomidate.


The risk or severity of adverse effects can be increased when alprostadil is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Tolcapone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with baclofen.


The risk or severity of adverse effects can be increased when indomethacin is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with estrone.


The risk or severity of adverse effects can be increased when felodipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when amoxapine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with thiothixene.


The risk or severity of adverse effects can be increased when Rufinamide is combined with hydromorphone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when clorazepate is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Perospirone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when biperiden is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with quetiapine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with triamterene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Retigabine.


The risk or severity of adverse effects can be increased when thiopental is combined with paroxetine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when haloperidol is combined with topiramate.


The risk or severity of adverse effects can be increased when antipyrine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Tramadol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when benazepril is combined with meperidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when antipyrine is combined with amcinonide.


The risk or severity of adverse effects can be increased when ketorolac is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when quetiapine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when quetiapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ketorolac is combined with etodolac.


The risk or severity of adverse effects can be increased when nitric oxide is combined with triamterene.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with tizanidine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with mefloquine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with nadolol.


The risk or severity of adverse effects can be increased when fosinopril is combined with Apremilast.


The risk or severity of adverse effects can be increased when rasagiline is combined with formoterol.


The risk or severity of adverse effects can be increased when tiagabine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when prazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when barnidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when morphine is combined with bromazepam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with minoxidil.


The risk or severity of adverse effects can be increased when Treprostinil is combined with leflunomide.


The risk or severity of adverse effects can be increased when Torasemide is combined with Epirubicin.


The risk or severity of adverse effects can be increased when apomorphine is combined with nicardipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Perospirone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nimodipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when paroxetine is combined with protriptyline.


The risk or severity of adverse effects can be increased when midodrine is combined with dobutamine.


The risk or severity of adverse effects can be increased when citalopram is combined with MELPERONE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with vinorelbine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with clozapine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with bupivacaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Etomidate.


The risk or severity of adverse effects can be increased when nitric oxide is combined with metolazone.


The risk or severity of adverse effects can be increased when benzocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when levodopa is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when atenolol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when polythiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when polythiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when triflupromazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with trimipramine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with ondansetron.


The risk or severity of adverse effects can be increased when benazepril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when amsacrine is combined with clozapine.


The risk or severity of adverse effects can be increased when diazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when metaraminol is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with doxepin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when midodrine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when gabapentin is combined with scopolamine.


The risk or severity of adverse effects can be increased when timolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with risperidone.


The risk or severity of adverse effects can be increased when METYROSINE is combined with nefazodone.


The risk or severity of adverse effects can be increased when suprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when morphine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when rasagiline is combined with periciazine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with loteprednol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when zopiclone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with thiothixene.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with methoxamine.


The risk or severity of adverse effects can be increased when morphine is combined with midazolam.


The risk or severity of adverse effects can be increased when benztropine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when lorazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when meprobamate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with topiramate.


The risk or severity of adverse effects can be increased when butamben is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Articaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when probenecid is combined with mecamylamine.


The risk or severity of adverse effects can be increased when epirizole is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when cabergoline is combined with paroxetine.


The risk or severity of adverse effects can be increased when enalapril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with streptozocin.


The risk or severity of adverse effects can be increased when enalapril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with doxepin.


The risk or severity of adverse effects can be increased when protriptyline is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with procarbazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with hydralazine.


The risk or severity of adverse effects can be increased when minoxidil is combined with indapamide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when furosemide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when scopolamine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Alvimopan is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when betamethasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Halazepam.


The risk or severity of adverse effects can be increased when LISURIDE is combined with vinblastine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with propofol.


The risk or severity of adverse effects can be increased when amobarbital is combined with proparacaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with trimipramine.


The risk or severity of adverse effects can be increased when Linagliptin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when selegiline is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with epirizole.


The risk or severity of adverse effects can be increased when flumethasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Perospirone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when sulindac is combined with equilin.


The risk or severity of adverse effects can be increased when carprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Agomelatine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Bretylium.


The risk or severity of adverse effects can be increased when thiothixene is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with captopril.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Aliskiren.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when methadone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Retigabine.


The risk or severity of adverse effects can be increased when trazodone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nimesulide is combined with desoximetasone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with scopolamine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when furosemide is combined with sulpiride.


The risk or severity of adverse effects can be increased when furosemide is combined with digoxin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with dantrolene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when docetaxel is combined with altretamine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with tizanidine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Bretylium.


The risk or severity of adverse effects can be increased when secobarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Lenalidomide.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when ondansetron is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when promazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when promazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when promazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when sulindac is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with gabapentin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Olsalazine is combined with medrysone.


The risk or severity of adverse effects can be increased when secobarbital is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Clobetasone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when procarbazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when tiapride is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Naftifine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Naftifine is combined with nicardipine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when clozapine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Melatonin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when selegiline is combined with Isometheptene.


The risk or severity of adverse effects can be increased when butorphanol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Olopatadine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Etomidate.


The risk or severity of adverse effects can be increased when Naftifine is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with cisapride.


The risk or severity of adverse effects can be increased when naratriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Etomidate is combined with Melatonin.


The risk or severity of adverse effects can be increased when methoxamine is combined with celiprolol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when nabumetone is combined with Droxicam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with dantrolene.


The risk or severity of adverse effects can be increased when Naftifine is combined with gabapentin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with clemastine.


The risk or severity of adverse effects can be increased when haloperidol is combined with flurazepam.


The risk or severity of adverse effects can be increased when Naftifine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when resveratrol is combined with paramethasone.


The risk or severity of adverse effects can be increased when resveratrol is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with mecamylamine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when flunisolide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with fludiazepam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with indapamide.


The risk or severity of adverse effects can be increased when pimozide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when cerulenin is combined with bepridil.


The risk or severity of adverse effects can be increased when tolmetin is combined with diflunisal.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with amitriptyline.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nadolol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with efavirenz.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when quazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when clidinium is combined with venlafaxine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when nefazodone is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when THYMOL is combined with nifedipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when methysergide is combined with ranitidine.


The risk or severity of adverse effects can be increased when aspirin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with zotepine.


The risk or severity of adverse effects can be increased when metaproterenol is combined with isoproterenol.


The risk or severity of adverse effects can be increased when thalidomide is combined with minoxidil.


The risk or severity of adverse effects can be increased when levorphanol is combined with imipramine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when metoclopramide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when minoxidil is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when mepivacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when butalbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when clemastine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when sulindac is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Flupentixol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with papaverine.


The risk or severity of adverse effects can be increased when methadone is combined with levorphanol.


The risk or severity of adverse effects can be increased when flurazepam is combined with oxazepam.


The risk or severity of adverse effects can be increased when resveratrol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Asenapine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when clonidine is combined with quetiapine.


The risk or severity of adverse effects can be increased when flurazepam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when ketamine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when ketamine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when methylergonovine is combined with rabeprazole.


The risk or severity of adverse effects can be increased when flurazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with desipramine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when proparacaine is combined with cocaine.


The risk or severity of adverse effects can be increased when bifonazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when midazolam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when niflumic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with diflorasone.


The risk or severity of adverse effects can be increased when nystatin is combined with eperisone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when naratriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when naratriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Propiverine.


The risk or severity of adverse effects can be increased when metoprolol is combined with fosinopril.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with irbesartan.


The risk or severity of adverse effects can be increased when tacrolimus is combined with estramustine.


The risk or severity of adverse effects can be increased when Halazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when docetaxel is combined with actinomycin D.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Treprostinil is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when docetaxel is combined with lomefloxacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with zopiclone.


The risk or severity of adverse effects can be increased when sotalol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when tetracaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when lorazepam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when tetracaine is combined with clemastine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when halothane is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Normethadone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when clidinium is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when naloxone is combined with Naloxegol.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with felodipine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with cilazapril.


The risk or severity of adverse effects can be increased when Butethal is combined with Tolcapone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with manidipine.


The risk or severity of adverse effects can be increased when Butethal is combined with amitriptyline.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when temazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when flumethasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when zaleplon is combined with tetracaine.


The risk or severity of adverse effects can be increased when ketamine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Etomidate is combined with phenytoin.


The risk or severity of adverse effects can be increased when triazolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with clidinium.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with meperidine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when minocycline is combined with Bexarotene.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with imipramine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Salsalate is combined with formestane.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with clidinium.


The risk or severity of adverse effects can be increased when Salsalate is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when proparacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when cilazapril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when triamterene is combined with prazosin.


The risk or severity of adverse effects can be increased when ramipril is combined with papaverine.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with trimipramine.


The risk or severity of adverse effects can be increased when ramipril is combined with nifedipine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Salsalate is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when perphenazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when thioridazine is combined with zopiclone.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with carprofen.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Tianeptine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when pramipexole is combined with cilazapril.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Tapentadol.


The risk or severity of adverse effects can be increased when codeine is combined with gabapentin.


The risk or severity of adverse effects can be increased when minoxidil is combined with Telmisartan.


The risk or severity of adverse effects can be increased when mirtazapine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Etomidate.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when nicergoline is combined with bicalutamide.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with mecamylamine.


The risk or severity of adverse effects can be increased when diazepam is combined with ketamine.


The risk or severity of adverse effects can be increased when pramipexole is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when minoxidil is combined with methyldopa.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with triamcinolone.


The risk or severity of adverse effects can be increased when bepridil is combined with simvastatin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when cilazapril is combined with celecoxib.


The risk or severity of adverse effects can be increased when maprotiline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when fenbufen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when propylthiouracil is combined with clozapine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with flumethasone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when morphine is combined with loratadine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with efavirenz.


The risk or severity of adverse effects can be increased when lidocaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when clomipramine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when zaleplon is combined with amisulpride.


The risk or severity of adverse effects can be increased when clomipramine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when clomipramine is combined with bumetanide.


The risk or severity of adverse effects can be increased when benztropine is combined with scopolamine.


The risk or severity of adverse effects can be increased when procaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when barnidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when ethanol is combined with selegiline.


The risk or severity of adverse effects can be increased when Etomidate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when procarbazine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when salicylamide is combined with acemetacin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with desipramine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with indomethacin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with levodopa.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Drospirenone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when moclobemide is combined with sulpiride.


The risk or severity of adverse effects can be increased when sertraline is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with cetirizine.


The risk or severity of adverse effects can be increased when gabapentin is combined with fluvastatin.


The risk or severity of adverse effects can be increased when moclobemide is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when quetiapine is combined with prilocaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when amobarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when sertraline is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with triprolidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with spironolactone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with halothane.


The risk or severity of adverse effects can be increased when nalbuphine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when paroxetine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when dibucaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with meclizine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when cetirizine is combined with clomipramine.


The risk or severity of adverse effects can be increased when pentazocine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when diazepam is combined with chlormezanone.